Ирландия - английски - HPRA (Health Products Regulatory Authority)

glenmark pharmaceuticals europe limited - ropinirole - film coated tablet - 5 milligram

Великобритания - английски - MHRA (Medicines & Healthcare Products Regulatory Agency)

glenmark pharmaceuticals europe ltd - mometasone furoate - cutaneous cream - 1mg/1gram

Ирландия - английски - HPRA (Health Products Regulatory Authority)

glenmark pharmaceuticals s.r.o. - escitalopram oxalate - film-coated tablet - 15 milligram(s) - selective serotonin reuptake inhibitors; escitalopram

Ирландия - английски - HPRA (Health Products Regulatory Authority)

glenmark pharmaceuticals s.r.o. - escitalopram oxalate - film-coated tablet - 10 milligram(s) - selective serotonin reuptake inhibitors; escitalopram

Ирландия - английски - HPRA (Health Products Regulatory Authority)

glenmark pharmaceuticals s.r.o. - escitalopram oxalate - film-coated tablet - 20 milligram(s) - selective serotonin reuptake inhibitors; escitalopram

САЩ - английски - NLM (National Library of Medicine)

glenmark pharmaceuticals inc.,usa - trimipramine maleate (unii: 269k6498ld) (trimipramine - unii:6s082c9ndt) - trimipramine maleate capsules are indicated for the relief of symptoms of depression. endogenous depression is more likely to be alleviated than other depressive states. in studies with neurotic outpatients, the drug appeared to be equivalent to amitriptyline in the less-depressed patients but somewhat less effective than amitriptyline in the more severely depressed patients. in hospitalized depressed patients, trimipramine and imipramine were equally effective in relieving depression. the use of maois intended to treat psychiatric disorders with trimipramine maleate or within 14 days of stopping treatment with trimipramine maleate is contraindicated because of an increased risk of serotonin syndrome. the use of trimipramine maleate within 14 days of stopping an maoi intended to treat psychiatric disorders is also contraindicated (see warnings and dosage and administration ). starting trimipramine maleate in a patient who is being treated with maois such as linezolid or intravenous methylene blue is also co

Малайзия - английски - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

glenmark pharmaceuticals (malaysia) sdn. bhd. - ezetimibe -

САЩ - английски - NLM (National Library of Medicine)

glenmark pharmaceuticals inc.,usa - calcipotriene (unii: 143nq3779b) (calcipotriene - unii:143nq3779b) - calcipotriene 50 ug in 1 g - calcipotriene cream, 0.005%, is indicated for the treatment of plaque psoriasis. the safety and effectiveness of topical calcipotriene in dermatoses other than psoriasis have not been established. calcipotriene cream is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation. it should not be used by patients with demonstrated hypercalcemia or evidence of vitamin d toxicity. calcipotriene cream should not be used on the face.

САЩ - английски - NLM (National Library of Medicine)

glenmark pharmaceuticals inc., usa - clobetasol propionate (unii: 779619577m) (clobetasol - unii:adn79d536h) - clobetasol propionate ointment is a super-high potency corticosteroid formulation indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. treatment beyond 2 consecutive weeks is not recommended, and the total dosage should not exceed 50 grams per week because of the potential for the drug to suppress the hypothalamic-pituitary-adrenal (hpa) axis. use in pediatric patients under 12 years of age is not recommended. as with other highly active corticosteroids, therapy should be discontinued when control has been achieved. if no improvement is seen within 2 weeks, reassessment of the diagnosis may be necessary. clobetasol propionate ointment is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparations.

САЩ - английски - NLM (National Library of Medicine)

glenmark pharmaceuticals inc., usa - clindamycin phosphate (unii: eh6d7113i8) (clindamycin - unii:3u02el437c) - clindamycin phosphate gel is indicated in the treatment of acne vulgaris. in view of the potential for diarrhea, bloody diarrhea and pseudomembranous colitis, the physician should consider whether other agents are more appropriate (see contraindications, warnings and adverse reactions). clindamycin phosphate gel is contraindicated in individuals with a history of hypersensitivity to preparations containing clindamycin or lincomycin, a history of regional enteritis or ulcerative colitis, or a history of antibiotic-associated colitis.